In 2022, the value of the Pharmacokinetics Services Market stood at USD 3.71 Billion. Projections indicate that by 2032, this value will escalate to USD 6.99 Billion, exhibiting a steady growth rate of 7.3% throughout the forecast period. The driving forces behind this market revenue surge are the upsurge in drug research initiatives, heightened demand for individualized medications, and...